GlassScriptPhysician profile
Afshin Gabayan
NPI 1659412757
$45,486.34
in general payments reported to CMS, 2019-2025
93 companies · $6,422 in 2025
The $6,422 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,187 · 2020: $2,807 · 2021: $12K · 2022: $8,498 · 2023: $6,144 · 2024: $6,441 · 2025: $6,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $6,169 · Travel and Lodging: $1,004 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,383.48 |
| Consulting Fee | $6,169.00 |
| Travel and Lodging | $1,004.12 |
| Education | $449.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $8,389.14 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $3,968.31 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Kite Pharma, INC. | $3,520.59 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $2,815.21 | 2019-2025 | Enhertu, Lynparza, Calquence |
| Genzyme Corporation | $1,896.03 | 2019-2025 | |
| Janssen Biotech, INC. | $1,888.49 | 2019-2025 | Carvykti, Rybrevant, Darzalex |
| Janssen Scientific Affairs, LLC | $1,755.00 | 2023 | |
| Beigene USA, INC. | $1,678.24 | 2020 | |
| Seagen INC. | $1,545.62 | 2019-2023 | Adcetris |
| Janssen Global Services, LLC | $1,500.00 | 2021 | |
| Veloxis Pharmaceuticals, INC. | $1,254.12 | 2023 | |
| Daiichi Sankyo INC. | $1,165.24 | 2019-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $966.71 | 2020-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $882.90 | 2019-2023 | Imbruvica, Epkinly |
| Genentech USA, INC. | $855.84 | 2019-2025 | Polivy, Lunsumio, Venclexta |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $791.02 | 2019-2023 | Prolia |
| Incyte Corporation | $610.29 | 2019-2025 | Jakafi, Pemazyre, Monjuvi |
| Novartis Pharmaceuticals Corporation | $564.55 | 2019-2025 | |
| Abbvie INC. | $545.43 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $525.63 | 2019-2024 | Keytruda, Lynparza |
| Puma Biotechnology, INC. | $433.65 | 2019-2025 | Nerlynx |
| Sun Pharmaceutical Industries INC. | $380.39 | 2020-2025 | Yonsa |
| Gilead Sciences, INC. | $329.13 | 2021-2024 | Trodelvy |
| Regeneron Healthcare Solutions, INC. | $323.44 | 2019-2025 | Libtayo |
| Stemline Therapeutics INC. | $291.51 | 2023-2025 | Orserdu |
| Ipsen Biopharmaceuticals, INC | $274.85 | 2019-2025 | Onivyde |
| Beone Medicines USA, INC. | $262.16 | 2025 | Brukinsa |
| Astellas Pharma US INC | $254.88 | 2019-2025 | Vyloy, Padcev |
| Eisai INC. | $241.84 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $236.31 | 2021-2025 | |
| Tersera Therapeutics LLC | $231.07 | 2019-2025 | Zoladex, Quzyttir |
| Menarini Silicon Biosystems, INC. | $206.64 | 2023-2025 | Cellsearch |
| Lilly USA, LLC | $205.62 | 2023-2025 | Jaypirca, Verzenio |
| E.R. Squibb & Sons, L.L.C. | $205.42 | 2019-2020 | |
| Telix Pharmaceuticals | $202.63 | 2024-2025 | Illuccix |
| Genmab U.S., INC. | $202.38 | 2024-2025 | Epkinly |
| Emd Serono, INC. | $199.67 | 2019-2025 | |
| Novocure INC. | $195.41 | 2021-2025 | Optune Lua (Novottf-200t) |
| Syndax Pharmaceuticals, INC. | $189.28 | 2025 | Revuforj |
| Genentech, INC. | $177.45 | 2021 | |
| Exelixis INC. | $159.31 | 2019-2021 | |
| Mirati Therapeutics, INC. | $149.80 | 2023 | Krazati |
| Sumitomo Pharma America, INC. | $147.55 | 2023-2025 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $143.97 | 2023-2024 | Provenge |
| Tg Therapeutics, INC. | $140.05 | 2021 | |
| Tempus Ai, INC | $138.42 | 2024-2025 | Xt Cdx |
| Array Biopharma INC | $128.98 | 2023-2025 | Mektovi, Braftovi, Tukysa |
| Springworks Therapeutics, INC. | $126.51 | 2024-2025 | Ogsiveo, Gomekli |
| Taiho Oncology, INC. | $125.79 | 2021-2025 | |
| Global Blood Therapeutics, INC. | $123.15 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $121.24 | 2019 | |
| Karyopharm Therapeutics INC. | $117.78 | 2020-2023 | Xpovio |
| Jazz Pharmaceuticals INC. | $114.79 | 2021-2025 | |
| Celgene Corporation | $110.03 | 2019 | |
| Blueprint Medicines Corporation | $109.56 | 2021-2022 | |
| Ge Healthcare | $109.42 | 2022-2025 | |
| Spectrum Pharmaceuticals INC. | $102.69 | 2024-2025 | Rolvedon |
| Morphosys, US INC. | $95.77 | 2021-2023 | Monjuvi |
| Secura Bio, INC. | $87.75 | 2024-2025 | Copiktra |
| Acrotech Biopharma INC. | $85.90 | 2021-2024 | Beleodaq |
| Azurity Pharmaceuticals, INC. | $62.54 | 2025 | Danziten, Vivimusta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.30 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $48.56 | 2022 | |
| Alexion Pharmaceuticals, INC. | $46.33 | 2019 | |
| Myriad Genetic Laboratories, INC. | $45.25 | 2022-2025 | Prolaris |
| Cti Biopharma Corp. | $45.00 | 2022-2023 | Vonjo |
| Myovant Sciences INC. | $44.66 | 2022 | |
| Glaxosmithkline, LLC. | $43.81 | 2020 | |
| Sobi, INC | $43.46 | 2024-2025 | |
| Geron Corporation | $42.86 | 2025 | Rytelo |
| G1 Therapeutics, INC. | $40.00 | 2022 | |
| Agios Pharmaceuticals, INC. | $30.00 | 2025 | Pyrukynd |
| Iovance Biotherapeutics, INC. | $28.06 | 2025 | Amtagvi |
| Amneal Pharmaceuticals LLC | $27.40 | 2024 | Avastin, Neupogen, Neulasta |
| Tesaro, INC. | $26.55 | 2019 | |
| Fennec Pharmaceuticals, INC. | $25.00 | 2025 | Fyarro |
| Sanofi-Aventis U.S. LLC | $24.49 | 2019 | |
| Esteve Pharmaceuticals LLC | $24.00 | 2025 | Lysodren |
| Rigel Pharmaceuticals, INC. | $23.33 | 2023 | Tavalisse, Rezlidhia |
| Clovis Oncology, INC. | $21.47 | 2019 | |
| Pharmaessentia USA Corporation | $21.06 | 2025 | Besremi |
| Adc Therapeutics America, INC. | $20.80 | 2024 | |
| Progenics Pharmaceuticals, INC. | $20.00 | 2025 | |
| Pharmacosmos Therapeutics INC. | $20.00 | 2025 | Monoferric |
| Dova Pharmaceuticals | $18.25 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $17.39 | 2019 | |
| Heartflow, INC. | $17.22 | 2024 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,996.17 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afshin Gabayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.